Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Five researchers named winners of 2016 Elsevier Foundation Awards

Five researchers named winners of 2016 Elsevier Foundation Awards

Fasudil improves memory in rats, promotes degradation of toxic tau in the eyes of fruit flies

Fasudil improves memory in rats, promotes degradation of toxic tau in the eyes of fruit flies

Study sheds light on role of red raspberries in metabolically-based chronic diseases

Study sheds light on role of red raspberries in metabolically-based chronic diseases

Penn investigators devise new method to map 'transcriptome'

Penn investigators devise new method to map 'transcriptome'

New discovery takes medical professionals a leap forward to effectively diagnose Alzheimer's disease

New discovery takes medical professionals a leap forward to effectively diagnose Alzheimer's disease

Aging brains work differently than younger brains, say cognitive scientists

Aging brains work differently than younger brains, say cognitive scientists

Benzodiazepine dementia risk refuted

Benzodiazepine dementia risk refuted

Past experience alters the brain circuitry responsible for object recognition

Past experience alters the brain circuitry responsible for object recognition

Novel quantitative method may reduce or eliminate need for invasive biopsies

Novel quantitative method may reduce or eliminate need for invasive biopsies

Lamin nucleoskeleton disordered in Alzheimer's

Lamin nucleoskeleton disordered in Alzheimer's

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

People with traumatic brain injuries may have buildup of plaques related to Alzheimer's disease

Mercury may not thwart seafood brain benefits

Mercury may not thwart seafood brain benefits

BDNF gene expression signals cognitive reserve against AD progression

BDNF gene expression signals cognitive reserve against AD progression

NJHF awards 30 grants for NJ researchers working on health-related research

NJHF awards 30 grants for NJ researchers working on health-related research

Seafood consumption may benefit older adults at risk for Alzheimer's disease

Seafood consumption may benefit older adults at risk for Alzheimer's disease

Saliva gland test may help diagnose early Parkinson's disease

Saliva gland test may help diagnose early Parkinson's disease

Understanding crucial role of 'healthy' brain in preventing memory failures linked to Alzheimer's disease

Understanding crucial role of 'healthy' brain in preventing memory failures linked to Alzheimer's disease

Study reveals increased mortality risk following hypertensive disease of pregnancy

Study reveals increased mortality risk following hypertensive disease of pregnancy

Scientific breakthrough could contribute to early diagnosis of osteoporosis, Alzheimer's

Scientific breakthrough could contribute to early diagnosis of osteoporosis, Alzheimer's

FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.